| Drug Name |
Deferoxamine mesylate |
| Drug ID |
BADD_D00597 |
| Description |
Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. |
| Indications and Usage |
Used to treat acute iron or aluminum toxicity (an excess of aluminum in the body) in certain patients. Also used in certain patients with anemia who must receive many blood transfusions. |
| Marketing Status |
approved; investigational |
| ATC Code |
V03AC01 |
| DrugBank ID |
DB00746
|
| KEGG ID |
D01186
|
| MeSH ID |
D003676
|
| PubChem ID |
62881
|
| TTD Drug ID |
D0FJ8A
|
| NDC Product Code |
60505-6237; 63323-599; 17337-0060; 46014-1127; 46014-1003; 63323-597; 47781-624; 0078-0467; 0409-2337; 60505-6238; 51846-1016; 60505-6236; 68083-172; 68083-173 |
| UNII |
V9TKO7EO6K
|
| Synonyms |
Deferoxamine | Desferrioxamine | Desferioximine | Deferoxamine B | Desferrioxamine B | Deferoximine | Deferrioxamine B | Desferroxamine | Desferrioxamine B Mesylate | Mesylate, Desferrioxamine B | Deferoxamine Mesilate | Mesilate, Deferoxamine | Deferoxamine Mesylate | Mesylate, Deferoxamine | Deferoxamine Methanesulfonate | Methanesulfonate, Deferoxamine | Desferal |
